Skip to content

immuneXpresso

Maintenance Shutdown

Note

The immuneXpresso resource is currently shutdown for security maintenance. The resource will be available after the necessary security upgrades are complete.

While the resource is undergoing updates, this page provides access to site content. Please contact the ImmPort helpdesk for any additional queries: ImmPort_Helpdesk@immport.org

immuneXpresso Resource

About immuneXpresso

The immuneXpresso (iX) knowledgebase was developed by joint effort of the Shen-Orr Lab at the Technion-Israeli Institute of Technology and by the Northrop Grumman Information Technology Health Solutions team.

Funding for the project is provided by the Bioinformatics Integration Support Contract (BISC) Phase II contract to ImmPort, awarded by the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID), Division of Allergy, Immunology, and Transplantation (DAIT).

Download Data

Citing immuneXpresso

Please cite the following when using immuneXpresso:

Kveler, K., Starosvetsky, E., Ziv-Kenet, A., Kalugny, Y., Gorelik, Y., Shalev-Malul, G., AizenbudReshef, N., Dubovik, T., Briller, M., Campbell, J., Rieckmann, J.C., Asbeh, N., Rimar, D., Meissner, F., Wiser, J., Shen-Orr, S.S., 2018. Immune-centric network of cytokines and cells in disease context identified by computational mining of PubMed. Nat. Biotechnol.
doi:10.1038/nbt.4152